The board of directors of Alphamab Oncology announced that the engagement of Mr. SHUAI Qi Terry as the board secretary, a joint company secretary and an authorized representative of the Company was terminated with effect from December 7, 2020. The termination of Shuai's engagement is primarily due to the unresolved disputes between Shuai and the Company regarding performance objectives and certain employment terms. The Board announced that WANG Jin'nan the Company's director of investor relations, has been appointed as a joint company secretary and an authorized representative of the Company with effect from December 7, 2020. Ms. WANG Jin'nan has over ten years of experience in financing, investment and investor relationship management. Prior to joining the Company, she has been a manager of Duff & Phelps, primarily responsible for providing fairness opinion on equity transactions, financing, mergers and acquisitions and investment.